The week that passed by saw shares of Aimmune Therapeutics (AIMT) make the biggest weekly advance, gaining over 170%, as the peanut allergy drug maker is all set to be acquired by Nestle Health Science for $34.50 per share in cash. Now, let's take a look at some of the pharma stocks that merit attention in the coming week.
from RTT - Biotech https://ift.tt/2ET0jeH
via IFTTT
No comments:
Post a Comment